EMA reported on the gradual examination of the Russian Sputnik V vaccine 
COVID-19 “Sputnik V”, said during a briefing the representative of the regulator Fergus Sweeney, writes RIA Novosti.
He promised to inform when scientists move on to the next stage of checks. “We need to continue contacts with the applicant, to study the data that he has already provided,” said Sweeney.
EMA carried out a gradual examination procedure for five vaccines against coronavirus. These are CureVac, Sputnik V, the Chinese drug Sinovac, the French vaccine Sanofi Pasteur and the American Novavax. CureVac later withdrew its application for evaluation. Novavax received from the agency the opportunity to apply for a marketing authorization. To date, four vaccines are authorized in the European Union: Moderna, J&J, AstraZeneca and Pfizer/BioNTech.
Earlier, virologist Anatoly Altshtein predicted the timing of the approval of Sputnik V by the European Union. According to him, if the World Health Organization (WHO) approves the Russian drug by the end of 2021, then the European regulator, EMA, can also do this.